September 30, 2026 at 08:18 PM UTC
MoonLake Immunotherapeutics reports additional corporate update
MoonLake Immunotherapeutics filed an 8-K covering other material corporate events. Nelo verified the filing topics against the primary SEC document. This is a company disclosure filed with the SEC, not an SEC enforcement action.
Official source: U.S. Securities and Exchange Commission
Official source published: September 30, 2026 at 08:15 PM UTC
Open official source